An expedited strategy for accurate and timely integrated molecular diagnosis of gliomas
Neuro Oncol
.
2023 Apr 6;25(4):808-809.
doi: 10.1093/neuonc/noad007.
Authors
Timothy A Gregory
1
,
Garret L Williford
1
,
Jacob M Maronge
2
,
Kristin Alfaro
1
,
Gregory N Fuller
3
,
John de Groot
1
,
Vinay K Puduvalli
1
,
Leomar Y Ballester
3
,
Nazanin K Majd
1
Affiliations
1
Department of Neuro-Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
2
Department of Biostatistics, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
3
Department of Neuropathology, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
PMID:
36723868
PMCID:
PMC10076931
DOI:
10.1093/neuonc/noad007
No abstract available
Publication types
Letter
MeSH terms
Brain Neoplasms* / diagnosis
Glioma* / diagnosis
Humans
Grants and funding
K08 CA241651/CA/NCI NIH HHS/United States